Literature DB >> 10362129

Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma.

F Lerebours1, S Olschwang, B Thuille, A Schmitz, P Fouchet, B Buecher, N Martinet, F Galateau, G Thomas.   

Abstract

Several somatic genetic alterations have been described in non-small-cell lung carcinomas (NSCLC). Recurrent chromosomal deletions have suggested the presence of tumor-suppressor genes specifically involved in lung carcinogenesis. For one of these, 2 non-overlapping regions have been proposed on the short arm of chromosome 8, encompassing the LPL and NEFL genes. The LPL region has been extensively studied in NSCLC and other cancer types. Two genes, N33 and PRLTS, have been identified, but the small number of mutations excludes their involvement in the vast majority of tumors. In order to delineate a reliable region of deletional overlap on chromosome 8p in NSCLC, a series of 77 NSCLC was studied for 34 microsatellite polymorphisms distributed on chromosome 8p, using multiplex-PCR amplification. After purification of tumor nuclei by flow cytometry based on either the abnormal DNA index or the presence of a high expression of cytokeratin, allelic losses on chromosome 8p were observed in 39% of cases. Measurement of DNA index showed that 62% of tumors were hyperploid; allelic losses were more frequent in hyperploid than in diploid tumors (54% vs. 14%; p < 10(-4)). Deletions of part of the short arm were observed in 7 instances. Our data allow definition of an interval of common deletion, flanked by the loci D8S511 and D8S1992, where the putative tumor-suppressor gene might be localized.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362129     DOI: 10.1002/(sici)1097-0215(19990611)81:6<854::aid-ijc3>3.0.co;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Expression and functional characterization of platelet-derived growth factor receptor-like gene.

Authors:  Feng-Jie Guo; Wei-Jia Zhang; Ya-Lin Li; Yan Liu; Yue-Hui Li; Jian Huang; Jia-Jia Wang; Ping-Li Xie; Guan-Cheng Li
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

3.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

4.  Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.

Authors:  Hongyi Yang; Yuhua Song
Journal:  J Mol Model       Date:  2016-03-19       Impact factor: 1.810

5.  How strong is the association between IPF and lung cancer? An answer from airway's DNA.

Authors:  G E Carpagnano; D Lacedonia; P Soccio; I Caccavo; G Patricelli; M P Foschino Barbaro
Journal:  Med Oncol       Date:  2016-09-29       Impact factor: 3.064

6.  NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients.

Authors:  Xiao-Qing Li; Lin Li; Chun-Hua Xiao; Yu-Mei Feng
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

7.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

8.  An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer.

Authors:  Min Xu; Ming-Chih J Kao; Juan Nunez-Iglesias; Joseph R Nevins; Mike West; Xianghong Jasmine Zhou
Journal:  BMC Genomics       Date:  2008       Impact factor: 3.969

9.  Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.

Authors:  Jacob R Manjarrez; Liang Sun; Thomas Prince; Robert L Matts
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

10.  Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.

Authors:  Núria Bonifaci; Antoni Berenguer; Javier Díez; Oscar Reina; Ignacio Medina; Joaquín Dopazo; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Med Genomics       Date:  2008-12-18       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.